The food additive vanillic acid controls transgene expression in mammalian cells and mice

被引:88
作者
Gitzinger, Marc [1 ]
Kemmer, Christian [1 ]
Fluri, David A. [1 ,2 ]
El-Baba, Marie Daoud [3 ]
Weber, Wilfried [1 ,4 ,5 ]
Fussenegger, Martin [1 ]
机构
[1] Swiss Fed Inst Technol, Dept Biosyst Sci & Engn D BSSE, CH-4058 Basel, Switzerland
[2] Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON, Canada
[3] Univ Lyon, F-69622 Villeurbanne, France
[4] Univ Freiburg, Fac Biol, D-79104 Freiburg, Germany
[5] Univ Freiburg, BIOSS Ctr Biol Signaling Studies, D-79104 Freiburg, Germany
基金
瑞士国家科学基金会;
关键词
PRODUCT GENE-EXPRESSION; NEURO-2A CELLS; TRANSCRIPTION; SYSTEM; TETRACYCLINE; CLONING; DEMETHYLASE; TECHNOLOGY; OSCILLATOR; COMPONENTS;
D O I
10.1093/nar/gkr1251
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Trigger-inducible transcription-control devices that reversibly fine-tune transgene expression in response to molecular cues have significantly advanced the rational reprogramming of mammalian cells. When designed for use in future geneand cell-based therapies the trigger molecules have to be carefully chosen in order to provide maximum specificity, minimal side-effects and optimal pharmacokinetics in a mammalian organism. Capitalizing on control components that enable Caulobacter crescentus to metabolize vanillic acid originating from lignin degradation that occurs in its oligotrophic freshwater habitat, we have designed synthetic devices that specifically adjust transgene expression in mammalian cells when exposed to vanillic acid. Even in mice transgene expression was robust, precise and tunable in response to vanillic acid. As a licensed food additive that is regularly consumed by humans via flavoured convenience food and specific fresh vegetable and fruits, vanillic acid can be considered as a safe trigger molecule that could be used for dietcontrolled transgene expression in future geneand cell-based therapies.
引用
收藏
页数:15
相关论文
共 69 条
[61]   Novel promoter/transactivator configurations for macrolide- and streptogramin-responsive transgene expression in mammalian cells [J].
Weber, W ;
Kramer, BP ;
Fux, C ;
Keller, B ;
Fussenegger, M .
JOURNAL OF GENE MEDICINE, 2002, 4 (06) :676-686
[62]   Artificial mammalian gene regulation networks - novel approaches for gene therapy and bioengineering [J].
Weber, W ;
Fussenegger, M .
JOURNAL OF BIOTECHNOLOGY, 2002, 98 (2-3) :161-187
[63]   Macrolide-based transgene control in mammalian cells and mice [J].
Weber, W ;
Fux, C ;
Daoud-El Baba, M ;
Keller, B ;
Weber, CC ;
Kramer, BP ;
Heinzen, C ;
Aubel, D ;
Bailey, JE ;
Fussenegger, M .
NATURE BIOTECHNOLOGY, 2002, 20 (09) :901-907
[64]   A synthetic mammalian gene circuit reveals antituberculosis compounds [J].
Weber, Wilfried ;
Schoenmakers, Ronald ;
Keller, Bettina ;
Gitzinger, Marc ;
Grau, Thomas ;
Baba, Marie Daoud-El ;
Sander, Peter ;
Fussenegger, Martin .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2008, 105 (29) :9994-9998
[65]   Vitamin H-regulated transgene expression in mammalian cells [J].
Weber, Wilfried ;
Bacchus, William ;
Baba, Marie Daoud-El ;
Fussenegger, Martin .
NUCLEIC ACIDS RESEARCH, 2007, 35 (17)
[66]   Inducible product gene expression technology tailored to bioprocess engineering [J].
Weber, Wilfried ;
Fussenegger, Martin .
CURRENT OPINION IN BIOTECHNOLOGY, 2007, 18 (05) :399-410
[67]   Pharmacologic transgene control systems for gene therapy [J].
Weber, Wilfried ;
Fussenegger, Martin .
JOURNAL OF GENE MEDICINE, 2006, 8 (05) :535-556
[68]   A biotin-triggered genetic switch in mammalian cells and mice [J].
Weber, Wilfried ;
Lienhart, Cedric ;
Baba, Marie Daoud-El ;
Fussenegger, Martin .
METABOLIC ENGINEERING, 2009, 11 (02) :117-124
[69]   Production of recombinant protein therapeutics in cultivated mammalian cells [J].
Wurm, FM .
NATURE BIOTECHNOLOGY, 2004, 22 (11) :1393-1398